Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology; D001479:Basal Ganglia / Q000187:drug effects*; D002118:Calcium; D002247:Carbon Isotopes; D002499:Centrifugation, Density Gradient; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D018492:Dopamine Antagonists; D066298:In Vitro Techniques; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D008297:Male; D008854:Microscopy, Electron; D010276:Parasympatholytics / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D013347:Subcellular Fractions; D013572:Synaptic Vesicles / Q000378:metabolism*; D013574:Synaptosomes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D013696:Temperature; D013997:Time Factors
D000978:Antiparkinson Agents; D002247:Carbon Isotopes; D018492:Dopamine Antagonists; D010276:Parasympatholytics; D011759:Pyrrolidines; D007770:L-Lactate Dehydrogenase; D002118:Calcium; D004298:Dopamine